The GLP is committed to full transparency. Download and review our Annual Report.

Roundup on trial: Cancer cases plateaued while glyphosate use exploded, Bayer expert witness testifies

Alva Pilliod’s lymphoma likely had no known cause, but his singularly abnormal immune system allowed it to flourish, an oncologist testified [May 6] in the latest trial over whether Monsanto’s top-selling weed killer Roundup causes cancer.

Monsanto wrapped its defense with testimony from Dr. Alexandra Levine, an oncologist with the City of Hope cancer center. Levine said decades of spraying Roundup did not contribute to Alva Pilliod’s illness.

She added: “My understanding is as glyphosate use increased substantially in the United States – and I understand it’s one of the most commonly used substance of its kind – if this really were a major cause of non-Hodgkin lymphoma I would have seen the rate of non-Hodgkin lymphoma go up just as I saw it go up when something new called HIV came up. But I don’t see that” …. She attributed the rise in non-Hodgkin lymphoma in the 1980s to the AIDS epidemic.

Related article:  Are your food choices killing you?

Under questioning from Monsanto attorney Tarek Ismail, Levine testified instances of non-Hodgkin lymphoma have plateaued in the last 20 years even while the use of glyphosate, the main chemical in Roundup, has drastically increased in the United States.

Read full, original article: Cancers Plateaued as Roundup Use Grew, Jury Hears

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend